Factors affecting tnf-? decrease in covid-19 patients

dc.contributor.authorGülhan, Muhammet
dc.contributor.authorAlpay, Merve
dc.contributor.authorYıldız, Sule
dc.contributor.authorYaslı, Nevra Ezgi
dc.contributor.authorAcat, Murat
dc.contributor.authorKahraman, Gözde
dc.contributor.authorArbak, Peri
dc.date.accessioned2024-09-29T16:30:59Z
dc.date.available2024-09-29T16:30:59Z
dc.date.issued2024
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAim: Tumor necrosis factor-alpha (TNF-?) have several functions, including cell survival, differentiation, and proliferation. TNF-? may effect the cell death during the cytokine storm that occurred during COVID-19 infection. We aimed to investigate, the factors that affects the TNF-? decrease in COVID-19 patients. Material and Methods: Totally 44 individuals with COVID-19 infection were included the study. Blood counts, biochemical examinations and D-dimer examinations were obtained. Comorbidities and initial symptoms of the patients were recorded. TNF-?, CRP and ferritin values were measured twice on the 1st and 7th days of hospitalization. The change in this values were examined according to comorbidities, initial symptoms and steroid usage. Results: Of a total of 44 patients, 56.8% were male (25/44) and 43.2 % were female (19/44). TNF-? decrease was found to be statistically significant in non-diabetic patients, while TNF-? decrease was found to be insignificant in diabetic patients. CRP decrease was found to be statistically significant in both diabetic and non-diabetic patients while ferritin decrease was insignificant in both diabetic and non-diabetic patients. While TNF-? and CRP decreased statistically significantly in those without lung disease, it was observed that both TNF-? and CRP decreases were not significant in those with lung disease. The decrease in TNF-? and CRP was statistically insignificant in those who did not treated with steroids, while the decrease in TNF-? and CRP was significant in those who treated with steroids. Conclusion: Steroids decreases the TNF-? levels. TNF decrease is not significant in those with diabetes and lung disease.en_US
dc.identifier.doi10.33631/sabd.1240226
dc.identifier.endpage53en_US
dc.identifier.issue1en_US
dc.identifier.startpage46en_US
dc.identifier.trdizinid1221705en_US
dc.identifier.urihttps://doi.org/10.33631/sabd.1240226
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1221705
dc.identifier.urihttps://hdl.handle.net/20.500.14619/11037
dc.identifier.volume14en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofSağlık bilimlerinde değer (Online)en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleFactors affecting tnf-? decrease in covid-19 patientsen_US
dc.typeArticleen_US

Dosyalar